Published in J Clin Microbiol on December 01, 1997
Quantitation of human immunodeficiency virus type 1 in breast milk. J Clin Microbiol (2003) 1.42
Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (1999) 1.32
Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands. PLoS One (2009) 1.20
Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol (1999) 1.07
Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1. J Infect Dis (1999) 1.04
Comparison of levels of human immunodeficiency virus type 1 RNA in plasma as measured by the NucliSens nucleic acid sequence-based amplification and Quantiplex branched-DNA assays. J Clin Microbiol (1999) 1.03
Associations of common variants in the BST2 region with HIV-1 acquisition in African American and European American people who inject drugs. AIDS (2015) 0.85
Use of rapid HIV assays as supplemental tests in specimens with repeatedly reactive screening immunoassay results not confirmed by HIV-1 Western blot. J Clin Virol (2013) 0.77
Gastrointestinal viral load and enteroendocrine cell number are associated with altered survival in HIV-1 infected individuals. PLoS One (2013) 0.77
Comparison of Roche MONITOR and Organon Teknika NucliSens assays to quantify human immunodeficiency virus type 1 RNA in cerebrospinal fluid. J Clin Microbiol (2001) 0.76
Obtaining unacceptable results in assays for quantitation of human immunodeficiency virus type 1 RNA in plasma samples. J Clin Microbiol (2000) 0.75
Rapid and simple method for purification of nucleic acids. J Clin Microbiol (1990) 44.73
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (1995) 34.97
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science (1993) 12.22
Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med (1996) 7.06
Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med (1995) 6.90
Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol (1994) 6.76
Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science (1995) 4.98
Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol (1996) 4.81
Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). J Infect Dis (1995) 4.60
Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction. J Infect Dis (1991) 2.86
Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (1996) 2.45
Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection. J Virol Methods (1993) 2.24
Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis (1994) 2.15
Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction. J Clin Microbiol (1993) 1.94
Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (1996) 1.75
Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J Clin Microbiol (1993) 1.53
Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR. J Virol Methods (1995) 1.11
Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.86
Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med (1996) 3.61
Crystal structure of human intrinsic factor: cobalamin complex at 2.6-A resolution. Proc Natl Acad Sci U S A (2007) 1.02
Human gastric intrinsic factor: characterization of cDNA and genomic clones and localization to human chromosome 11. Genomics (1991) 0.99
Stability of free and complexed human immunodeficiency virus type 1 antigen at 4 degrees C and at room temperature. J Clin Microbiol (1995) 0.87
Functional expression in Pichia pastoris of human and rat intrinsic factor. Biochim Biophys Acta (2000) 0.87
The intrinsic factor (IF)-cobalamin receptor binding site is located in the amino-terminal portion of IF. J Biol Chem (1992) 0.85
Synthesis of pyrrolizidine alkaloids indicine, intermedine, lycopsamine, and analogues and their N-oxides. Potential antitumor agents. J Med Chem (1985) 0.85
Prevalence of antibodies to human herpesvirus 8 (HHV-8) in Saudi Arabian patients with and without renal failure. Transplantation (2001) 0.84
Prevalence of persistent asymptomatic proteinuria in HIV-infected outpatients and lack of correlation with viral load. Clin Nephrol (2001) 0.82
Effect of stavudine on human immunodeficiency virus type 1 virus load as measured by quantitative mononuclear cell culture, plasma RNA, and immune complex-dissociated antigenemia. J Infect Dis (1996) 0.82
Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis. Kidney Int (1993) 0.81
Effect of protein source during weight loss on body composition, cardiometabolic risk and physical performance in abdominally obese, older adults: a pilot feeding study. J Nutr Health Aging (2015) 0.79
Acute renal failure complicating HELLP syndrome, SLE and anti-phospholipid syndrome: successful outcome using plasma exchange therapy. Lupus (2003) 0.78
Production of gastric intrinsic factor, transcobalamin, and haptocorrin in opossum kidney cells. Am J Physiol Renal Physiol (2000) 0.77
Improved medical and surgical management of cervical spine disease in patients with rheumatoid arthritis over 10 years. Ann Rheum Dis (2000) 0.77
Postcrystallization Analysis of the Irreproducibility of the Human Intrinsic Factor-Cobalamin Complex Crystals. Cryst Growth Des (2009) 0.76
Comparison of enzyme-linked immunosorbent and indirect immunofluorescence assays for the detection of human T-cell lymphotropic virus type-I antibodies in sera from rural Haiti. Diagn Microbiol Infect Dis (1992) 0.76
Human immunodeficiency virus (HIV) RNA quantitation using the Amplicor HIV-1 Monitor test: not all yellow-top tubes are suitable for blood collection. J Clin Microbiol (1997) 0.75
Osteoarthritis of the knee. Lancet (1997) 0.75
Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction? J Rheumatol (1996) 0.75
Antimalarials in the management of psoriatic arthritis? Clin Exp Rheumatol (2002) 0.75
Comparative performance of peptide-, recombinant protein-, and viral lysate-based enzyme immunosorbent assays for the detection of HIV-1 antibodies. Diagn Microbiol Infect Dis (1993) 0.75
A receptor binding site on intrinsic factor is located between amino acids 25-44 and interacts with other parts of the protein. Biochem Biophys Res Commun (1997) 0.75
Chemical ecology ofReticulitermes flavipes (Kollar) andR. virginicus (Banks) (Rhinotermitidae) : Chemistry of the soldier cephalic secretions. J Chem Ecol (1981) 0.75